User profiles for Linda A. DiMeglio
 | Linda A. DiMeglioIndiana University School of Medicine Verified email at iu.edu Cited by 23016 |
Global consensus recommendations on prevention and management of nutritional rickets
…, L Ramos-Abad, L Ward, LA DiMeglio… - The Journal of …, 2016 - academic.oup.com
Background: Vitamin D and calcium deficiencies are common worldwide, causing nutritional
rickets and osteomalacia, which have a major impact on health, growth, and development …
rickets and osteomalacia, which have a major impact on health, growth, and development …
Type 1 diabetes
… Prof Linda A DiMeglio Linda A DiMeglio … Correspondence to: Prof Linda A DiMeglio,
Department of Pediatrics, Indiana University School of Medicine, Indianapolis, 46202 IN, USA …
Department of Pediatrics, Indiana University School of Medicine, Indianapolis, 46202 IN, USA …
Current state of type 1 diabetes treatment in the US: updated data from the T1D Exchange clinic registry
…, RM Bergenstal, SN DuBose, LA DiMeglio… - Diabetes …, 2015 - Am Diabetes Assoc
To examine the overall state of metabolic control and current use of advanced diabetes
technologies in the US, we report recent data collected on individuals with type 1 diabetes …
technologies in the US, we report recent data collected on individuals with type 1 diabetes …
[PDF][PDF] ISPAD Clinical Practice Consensus Guidelines 2018: Glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes
This is the author's manuscript of the article published in final edited form as: DiMeglio, LA,
Acerini, CL, Codner, E., Craig, ME, Hofer, SE, Pillay, K., & Maahs, DM (2018). ISPAD Clinical …
Acerini, CL, Codner, E., Craig, ME, Hofer, SE, Pillay, K., & Maahs, DM (2018). ISPAD Clinical …
[HTML][HTML] An anti-CD3 antibody, teplizumab, in relatives at risk for type 1 diabetes
…, SA Long, JA Bluestone, LA DiMeglio… - … England Journal of …, 2019 - Mass Medical Soc
Background Type 1 diabetes is a chronic autoimmune disease that leads to destruction of
insulin-producing beta cells and dependence on exogenous insulin for survival. Some …
insulin-producing beta cells and dependence on exogenous insulin for survival. Some …
Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial
T Orban, B Bundy, DJ Becker, LA DiMeglio… - The Lancet, 2011 - thelancet.com
Background The immunopathogenesis of type 1 diabetes mellitus is associated with T-cell
autoimmunity. To be fully active, immune T cells need a co-stimulatory signal in addition to the …
autoimmunity. To be fully active, immune T cells need a co-stimulatory signal in addition to the …
Most youth with type 1 diabetes in the T1D Exchange Clinic Registry do not meet American Diabetes Association or International Society for Pediatric and Adolescent …
OBJECTIVE To assess the proportion of youth with type 1 diabetes under the care of pediatric
endocrinologists in the United States meeting targets for HbA 1c , blood pressure (BP), BMI…
endocrinologists in the United States meeting targets for HbA 1c , blood pressure (BP), BMI…
Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine
Precision medicine is part of the logical evolution of contemporary evidence-based medicine
that seeks to reduce errors and optimize outcomes when making medical decisions and …
that seeks to reduce errors and optimize outcomes when making medical decisions and …
Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial
DK Wherrett, B Bundy, DJ Becker, LA DiMeglio… - The Lancet, 2011 - thelancet.com
Background Glutamic acid decarboxylase (GAD) is a major target of the autoimmune response
that occurs in type 1 diabetes mellitus. In animal models of autoimmunity, treatment with a …
that occurs in type 1 diabetes mellitus. In animal models of autoimmunity, treatment with a …
Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials
A Moran, B Bundy, DJ Becker, LA DiMeglio… - The Lancet, 2013 - thelancet.com
Background Innate immunity contributes to the pathogenesis of autoimmune diseases, such
as type 1 diabetes, but until now no randomised, controlled trials of blockade of the key …
as type 1 diabetes, but until now no randomised, controlled trials of blockade of the key …